News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
NextUP Program Provides Impact Grant Funding for Promising Pre-commercial Penn Ideas and Technologies
Applicants must include a Penn faculty member as a lead participant and an invention disclosure must be submitted to PCI.
Ascidian Therapeutics and Eli Lilly Establish Global Research Partnership
Ascidian was founded with technology developed by Jean Bennett, MD, PhD.
Exyn Technologies Completes a Successful IPO
Exyn raised $19.4 million in an initial public stock offering in May.
Meet the Penn I-Corps Spring 2026 Teams
The Spring 2026 teams have completed the Penn I-Corps program.
Craig Gravitz, JD, Joins PCI as Executive Director of PCI Ventures
Gravitz joins PCI from the Advanced Research Projects Agency for Health (ARPA‑H).
Penn Scientist Elected President of Leading Cancer Organization
In this role, he aims to advance innovation in cancer treatment and prevention.
Penn Vet Researchers Target Tumor-Supporting Cells to Advance CAR T Treatment in Pancreatic Cancer
This approach may pave the way for potentially safer, more accessible, and cost-effective treatments for solid tumors.
Mitchell Lab Engineers LNPs to Enhance mRNA Vaccine Efficacy, Reduce Side Effects
Mitchell and his team discovered that lipid nanoparticles (LNPs) can be used to modify the metabolism of immune cells.
Penn Engineering Researchers Use Topology to Build More Robust Photonic Networks
Researchers leveraged topological design principles to develop stable chip networks that guide multiple light signals at once.
NIH Director Jay Bhattacharya and Senator Dave McCormick Visit Penn Medicine
The visit included meetings with researchers, clinicians, and innovators at Penn and a tour of one of Penn’s CAR T cell laboratories.